Results 231 to 240 of about 6,542,588 (257)
Some of the next articles are maybe not open access.
Approach to the Patient: Case Studies in Pediatric Growth Hormone Deficiency and Their Management
The Journal of Clinical Endocrinology & Metabolism, 2023Abstract Context Pathologies attributed to perturbations of the GH/IGF-I axis are among the most common referrals received by pediatric endocrinologists. Aim In this article, distinctive cased-based presentations are used to provide a
Rohan K Henry, Bradley S Miller
openaire +2 more sources
Therapy for Pediatric Brain Tumors and the Risk of Growth Hormone Deficiency
Journal of Clinical Oncology, 2011REFERENCES 1. Breuer B, Fleishman SB, Cruciani RA, et al: Medical oncologists’ attitudes and practice in cancer pain management: A national survey. J Clin Oncol 29:4769-4775, 2011 2. von Gunten CF: Arrogance ignorance paradox. J Palliat Med 8:898-899, 2005 3.
Charles, Sklar, Suzanne, Wolden
openaire +2 more sources
Journal of Endocrinological Investigation, 2011
In the literature, few studies analyze the effect of GH therapy on height, preferring a more indirect approach, where factors influencing the total pubertal and pre-pubertal growth in GH-deficient patients are evaluated and subsequently used to estimate the overall effect at the end of the therapy; unfortunately, this approach does not quantify the ...
Migliaretti, G +15 more
openaire +5 more sources
In the literature, few studies analyze the effect of GH therapy on height, preferring a more indirect approach, where factors influencing the total pubertal and pre-pubertal growth in GH-deficient patients are evaluated and subsequently used to estimate the overall effect at the end of the therapy; unfortunately, this approach does not quantify the ...
Migliaretti, G +15 more
openaire +5 more sources
Management options for pediatric growth hormone deficiency
Expert Opinion on Orphan Drugs, 2019Introduction: Growth hormone deficiency (GHD), in 1:4000 children, is congenital or acquired inability to produce serum GH from the pituitary.
openaire +1 more source
Pediatric growth hormone deficiency.
Journal of intravenous nursing : the official publication of the Intravenous Nurses Society, 1998Current information on the pathophysiology, diagnostic process, and treatment of growth hormone deficiency is provided. A case study is provided that shows the positive effects of growth hormone therapy on a patient and his family. Information regarding the intravenous clinician's role in administration of growth hormone and patient teaching also is ...
openaire +1 more source
Child's Nervous System, 2019
The safety and efficacy of growth hormone replacement therapy (GHRT) on pediatric patients with growth hormone deficiency (GHD) and Chiari I malformation (CIM) are not well investigated within the current body of literature. With no clear indication of the effects of GHRT on CIM disease progression, we sought to determine the effect of GHRT on ...
Harrison Ballard +4 more
openaire +2 more sources
The safety and efficacy of growth hormone replacement therapy (GHRT) on pediatric patients with growth hormone deficiency (GHD) and Chiari I malformation (CIM) are not well investigated within the current body of literature. With no clear indication of the effects of GHRT on CIM disease progression, we sought to determine the effect of GHRT on ...
Harrison Ballard +4 more
openaire +2 more sources
Genetic basis of growth hormone deficiency: An update for pediatric endocrinologists
Journal of Pediatric Endocrinology and DiabetesGrowth hormone deficiency (GHD) is the most common anterior pituitary hormone deficiency. It may occur either in isolation (isolated GHD [IGHD]) or in combination with one or more other pituitary hormone deficiencies (multiple pituitary hormone deficiency, MPHD).
Ruchi Nadar +2 more
openaire +1 more source
A lifetime of growth hormone deficiency: a US pediatric perspective.
Journal of pediatric endocrinology & metabolism : JPEM, 2001At a dose of approximately 0.3 mg/kg/week, treatment with growth hormone (GH) in GH-deficient children achieves adult heights that are in close proximity to a final height SDS of -0.7 +/- 1.3 for males and -0.7 +/- 1.1 for females. Early diagnosis, treatment with adequate doses of GH and attention to compliance with therapy have contributed to these ...
openaire +1 more source